Skip to main content
Home
  • Diagnostics
    • About
    • Diagnostics Lab Meeting Summaries
    • Diagnostics Parallel Analysis Workgroup
  • Therapeutics
    • About
    • Therapeutics Lab Meeting Summaries
    • Therapeutics Parallel Analysis Workgroup
  • Vaccines
    • About
  • News & Events
    • News
  • Blog
  • RWE Primer
Home
  • Diagnostics
    • About
    • Diagnostics Lab Meeting Summaries
    • Diagnostics Parallel Analysis Workgroup
  • Therapeutics
    • About
    • Therapeutics Lab Meeting Summaries
    • Therapeutics Parallel Analysis Workgroup
  • Vaccines
    • About
  • News & Events
    • News
  • Blog
  • RWE Primer

Breadcrumb

  1. Home
  2. data analytics
  • facebook
  • twitter
  • email
  • print

Working Toward Data Interoperability

Working Toward Data Interoperability

Image
Working Toward Data Interoperability
When talking about data interoperability, researchers should understand that most data issues can be traced back to a lack of alignment.
  • facebook
  • twitter
  • email
  • print

Evidence Accelerator Model – A Critical Catalyst Towards A Learning Health System

Evidence Accelerator Model – A Critical Catalyst Towards A Learning Health System

Image
Evidence Accelerator Model
Our national and global shared experience with COVID-19 crystallized the criticality of near real-time, real-world data (RWD) to generate insights and actionable information; and the imperative to drive towards a learning health system.
  • facebook
  • twitter
  • email
  • print

COVID-19 Evidence Accelerator workgroup to coordinate medication use definitions across Evidence Accelerator data partners

COVID-19 Evidence Accelerator workgroup to coordinate medication use definitions across Evidence Accelerator data partners

Image
Working Toward Data Interoperability

During a recent COVID-19 Evidence Accelerator (EvAcc) Therapeutics Parallel Analysis meeting1 we saw the synergy and creativity that arises when multiple partners work on the same data challenges.

Subscribe to data analytics

Reagan-Udall Foundation for the FDA

  • address 1333 New Hampshire Ave, NW
    Suite 420
    Washington, DC 20036
  • phone202 849 2075
  • web www.reaganudall.org
RUF Friends Logo
 
  • emailevidenceaccelerator@reaganudall.org

Friends of Cancer Research

  • address 1800 M Street NW, Suite 1050 South
    Washington, DC 20036
  • phone202 944 6700
  • web www.focr.org
  •